Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/bmj.m4514 | DOI Listing |
Qual Manag Health Care
October 2024
Author Affiliations: Health Unit, Mathematica, Inc., Princeton, NJ (Ms Felt-Lisk, Drs Chandler and Merrill); and Centers for Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Baltimore, MD (Ms Johnson, Drs Everhart and Flemming).
Background And Objectives: The Transforming Clinical Practices Initiative (TCPI) was a 4-year, large-scale, collaborative, peer-based learning initiative for physician practices of all specialties with broad goals to improve the quality of patient care, spend health care dollars more wisely, and assist practices in being ready to succeed under value-based payment (VBP). We investigated whether the COVID-19 pandemic had erased or diminished practice transformation progress made during the TCPI program period, through a follow-up survey of participating practices fielded in October 2021.
Methods: In October 2021 to April 2022, we surveyed a probability sample of 2207 primary care and specialty practices that participated in the TCPI, receiving 610 responses.
Contraception
August 2024
Department of Obstetrics, Gynecology & Women's Health, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Objectives: To evaluate the implementation of mifepristone and misoprostol for medical management of early pregnancy loss (EPL) in emergency departments (EDs) by comparing efficacy, complication, and follow-up rates for patients treated in EDs to the Complex Family Planning (CFP) outpatient office.
Study Design: In COVID-19's first wave, we expanded medical management of EPL to our EDs. This retrospective study evaluated 72 patients receiving mifepristone and misoprostol for EPL from April 1, 2020 to March 31, 2021, comparing treatment success, safety outcomes, and follow-up rates by location.
Front Med (Lausanne)
January 2024
Department of Oncology-Hematology, National Center for Cancer Care and Research - Hamad Medical Corporation, Doha, Qatar.
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus causing the coronavirus disease of 2019. The disease has caused millions of deaths since the first pandemic at the end of 2019. Immunocompromised individuals are more likely to develop severe infections.
View Article and Find Full Text PDFSci Rep
January 2024
Department of Bioengineering, Gebze Technical University, Kocaeli, Turkey.
A novel virus emerged from Wuhan, China, at the end of 2019 and quickly evolved into a pandemic, significantly impacting various industries, especially healthcare. One critical lesson from COVID-19 is the importance of understanding and predicting underlying comorbidities to better prioritize care and pharmacological therapies. Factors like age, race, and comorbidity history are crucial in determining disease mortality.
View Article and Find Full Text PDFBMC Oral Health
December 2023
Department of Oral Medicine, Oral Diagnosis and Radiology, Faculty of Dentistry, Alexandria University, Periodontology, Egypt.
Objective: There is growing evidence supporting the presence of oral manifestations associated with COVID-19. The study investigates the knowledge of dental undergraduates and recently graduated dentists concerning oral presentations related to COVID-19.
Methods: A cross-sectional descriptive study in Saudi Arabia comprised 305 individuals, including undergraduate dental students, interns, and freshly graduated dentists.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!